Study of interaction between PEG carrier and three relevant drug molecules: piroxicam, paclitaxel, and hematoporphyrin

The Journal of Physical Chemistry. B
Yen-Chin LiAlex Bunker

Abstract

Molecular dynamics simulation has been used to study the specific interactions between poly(ethylene glycol) (PEG) and three drug molecules for which PEG is used to aid delivery: paclitaxel and piroxicam, where PEG is a carrier agent, and hematoporphyrin, where PEG is covalently attached to form a "stealth shield". Simulating at physiological salt concentration, we found no evidence of any specific interaction between paclitaxel or piroxicam with PEG, but found a strong interaction for the case of hematoporphyrin. This interaction is lipophilic in nature, between the nonpolar (CH(2))(2) groups of the PEG and the porphin ring of the hematoporphyrin. This interaction was found to be strong enough that the PEG aggregated to the hematoporphyrin, independent of whether or not it was covalently bound. Interestingly, when the simulation was repeated in absence of salt we found evidence of this interaction being weakened. This led us to hypothesize a previously unforeseen mechanism: interaction with salt cations cause the PEG to coil around the salt ions, each ion binding to many PEG oxygens, increasing the exposure of the nonpolar ethylene groups, thus increasing the effective hydrophobicity of PEG. The Hydrophobic ethylene groups of ...Continue Reading

References

Sep 1, 1971·Journal of Pharmaceutical Sciences·W L Chiou, S Riegelman
Feb 14, 1971·Journal of Molecular Biology·B Lee, F M Richards
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Mar 1, 1985·Physical Review A: General Physics·W G Hoover
Jun 11, 1999·International Journal of Pharmaceutics·A B Dhanikula, R Panchagnula
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C Leuner, J Dressman
Jul 29, 2000·Drug Development and Industrial Pharmacy·R N PanR R Chen
Mar 7, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·T OsterbergP Lundahl
Nov 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tooru OoyaKinam Park
Feb 3, 2004·Current Pharmaceutical Design·Giampaolo TortoraFortunato Ciardiello
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Christophe Olivier
Jul 21, 2006·The Journal of Physical Chemistry. B·Mariusz KepczyńskiMaria Nowakowska
Jun 19, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eunah KangJi-Xin Cheng
Feb 26, 2009·Journal of Computer-aided Molecular Design·Kazuya NakaoMiki Akamatsu
Jan 2, 2010·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Kely Ferreira de SouzaRogério Custodio
Aug 24, 2010·The Journal of Physical Chemistry. B·Michał StepniewskiTomasz Róg
Mar 31, 2011·Biochimica Et Biophysica Acta·Danor AharonBenjamin Ehrenberg
May 25, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Michał StepniewskiAlex Bunker
Mar 1, 2008·Journal of Chemical Theory and Computation·Berk HessErik Lindahl

❮ Previous
Next ❯

Citations

Apr 26, 2014·Physical Chemistry Chemical Physics : PCCP·Vladimir B TsvetkovNickolay S Melik-Nubarov
Oct 16, 2016·Journal of Porphyrins and Phthalocyanines·Krystal R FontenotM Graça H Vicente
Oct 15, 2013·Photochemistry and Photobiology·Timur M ZhiyentayevNickolay S Melik-Nubarov
Mar 2, 2016·Biochimica Et Biophysica Acta·M RamezanpourD P Tieleman
Apr 21, 2016·Molecular Pharmaceutics·Tatu LajunenArto Urtti
Dec 30, 2014·Journal of Biological Physics·Umesh YadavaMihir Roychoudhury
May 26, 2016·International Journal of Molecular Sciences·Ziyuan MengGe Zhang
Jul 12, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Priyanka A OroskarSohail Murad
Jan 15, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Natalia WilkoszMariusz Kepczynski
Mar 10, 2018·Pharmaceutical Research·Jasmin MonparaPradeep R Vavia
Sep 24, 2014·Beilstein Journal of Nanotechnology·Paula M CastilloAna P Zaderenko
Apr 5, 2016·Journal of Biophotonics·Ashwini A Ghogare, Alexander Greer
Dec 20, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Isabel de LaveraAna P Zaderenko
Dec 18, 2020·Frontiers in Molecular Biosciences·Alex Bunker, Tomasz Róg
Nov 28, 2020·Current Topics in Medicinal Chemistry·Chun ChanXiaolin Cheng
May 13, 2015·The Journal of Physical Chemistry. B·Monika DzieciuchMariusz Kepczynski
Nov 5, 2017·Langmuir : the ACS Journal of Surfaces and Colloids·Xinghong DuoWencheng Zhang
Feb 17, 2015·The Journal of Physical Chemistry. B·Goutam GhoshAlexander Greer
Oct 29, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Eol Han, Hwankyu Lee
Dec 20, 2013·The Journal of Physical Chemistry. B·Sami RissanenTomasz Róg
Sep 28, 2021·ACS Applied Materials & Interfaces·Guang-Rong TanYong Zhang
Jul 12, 2017·International Journal of Pharmaceutics·Maikel HerbrinkBastiaan Nuijen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.